Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

SHE:002399 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,422	1,852	2,139	2,944	2,712
Short-Term Investments	267.14	-	-	-	74.21
Trading Asset Securities	867.9	414.18	1,312	981.16	828.21
Cash & Short-Term Investments	2,557	2,266	3,450	3,925	3,615
Cash Growth	12.84%	-34.33%	-12.10%	8.59%	159.98%
Accounts Receivable	1,187	1,275	1,626	1,543	1,694
Other Receivables	51.8	120.43	134.82	243.81	184.16
Receivables	1,239	1,395	1,761	1,787	1,878
Inventory	5,394	6,654	6,844	4,708	3,168
Other Current Assets	431.85	289.01	334.53	349.43	467.34
Total Current Assets	9,621	10,604	12,390	10,770	9,129
Property, Plant & Equipment	2,854	2,634	2,477	2,537	2,571
Long-Term Investments	1,823	2,514	2,464	2,618	3,999
Goodwill	2,357	2,322	2,351	2,152	2,203
Other Intangible Assets	306.68	474.57	522.87	546.87	615.95
Long-Term Deferred Tax Assets	282.51	320.5	141.48	121.72	83.94
Long-Term Deferred Charges	-	211.07	244.71	241.88	230.33
Other Long-Term Assets	98.61	122.79	224.95	120.85	194.36
Total Assets	17,344	19,203	20,816	19,108	19,026
Accounts Payable	299.69	302.22	427.43	385.79	239.22
Accrued Expenses	-	371.92	377.51	398.43	395.33
Short-Term Debt	-	1,881	2,385	1,886	1,860
Current Portion of Long-Term Debt	2,367	1,744	1,635	1,382	622.21
Current Portion of Leases	38.82	37.8	35.69	31.75	25.6
Current Income Taxes Payable	120.26	157.18	112.3	113.2	43.74
Current Unearned Revenue	264.28	366.17	433.88	383.79	265.04
Other Current Liabilities	609.02	126.32	168.2	210.34	161.93
Total Current Liabilities	3,699	4,986	5,576	4,791	3,613
Long-Term Debt	1,081	1,810	2,297	2,250	3,086
Long-Term Leases	57.77	90.42	110.75	104	51.64
Long-Term Unearned Revenue	27.29	30.43	32.55	16.67	18.74
Long-Term Deferred Tax Liabilities	242.49	252.57	328.92	275.36	427.67
Other Long-Term Liabilities	10.35	14.31	29.39	26.44	24.76
Total Liabilities	5,141	7,215	8,407	7,585	7,337
Common Stock	1,467	1,467	1,467	1,467	1,467
Additional Paid-In Capital	-	6,356	5,859	5,944	6,035
Retained Earnings	-	3,931	4,861	4,184	4,212
Comprehensive Income & Other	10,681	158.46	125.52	-183.36	-145.09
Total Common Equity	12,149	11,913	12,313	11,411	11,569
Minority Interest	53.45	75.23	96.72	111.96	119.6
Shareholders' Equity	12,202	11,988	12,409	11,523	11,689
Total Liabilities & Equity	17,344	19,203	20,816	19,108	19,026
Total Debt	3,545	5,563	6,464	5,654	5,645
Net Cash (Debt)	-987.94	-3,297	-3,013	-1,729	-2,030
Net Cash Per Share	-0.67	-2.25	-2.05	-1.18	-1.50
Filing Date Shares Outstanding	1,467	1,467	1,467	1,467	1,467
Total Common Shares Outstanding	1,467	1,467	1,467	1,467	1,467
Working Capital	5,922	5,618	6,814	5,978	5,516
Book Value Per Share	8.28	8.12	8.39	7.78	7.88
Tangible Book Value	9,485	9,116	9,439	8,712	8,751
Tangible Book Value Per Share	6.46	6.21	6.43	5.94	5.96
Land	-	34	33.43	30.61	31.32
Buildings	-	1,791	1,480	1,450	1,445
Machinery	-	1,952	1,892	1,719	1,693
Construction In Progress	-	468.72	394.53	425.35	364.39

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.